Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic’ and ‘cytotoxic’ are often used interchangeably.
The classification of Cytotoxic Drug includes Injection, Solid Oral Dose Forms and others, and the proportion of Injection in 2016 is about 94%, and the proportion is in decreasing trend from 2012 to 2016.Cytotoxic Drug is widely used in Breast Cancer, Blood Cancer, Prostate Cancer, Respiratory/Lung Cancer and other diseases. The most proportion of Cytotoxic Drug is for other diseases, and the consumption proportion for blood cancer in 2016 is about 24%.Market competition is intense. Haosoh Pharma, Eli Lilly, Takeda, Roche, Sumitomo Dainippon Pharma, eisai, AstraZeneca, Seattle Genetics, Spectrum Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Cytotoxic Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Cytotoxic Drug market. Detailed analysis of key players, along with key growth strategies adopted by Cytotoxic Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Haosoh Pharma
Eli Lilly
Takeda
Roche
Sumitomo Dainippon Pharma
eisai
AstraZeneca
Seattle Genetics
Spectrum Pharma
Merck
Sanofi
Celgene
Novartis
Jazz Pharma
By Type:
Injection
Solid Oral Dose Forms
Others
By End-User:
Breast Cancer
Blood Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Cytotoxic Drug Market
-
1.3 Market Segment by Type
-
1.3.1 USA Cytotoxic Drug Market Size and Growth Rate of Injection from 2016 to 2027
-
1.3.2 USA Cytotoxic Drug Market Size and Growth Rate of Solid Oral Dose Forms from 2016 to 2027
-
1.3.3 USA Cytotoxic Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Cytotoxic Drug Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.4.2 USA Cytotoxic Drug Market Size and Growth Rate of Blood Cancer from 2016 to 2027
-
1.4.3 USA Cytotoxic Drug Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
1.4.4 USA Cytotoxic Drug Market Size and Growth Rate of Respiratory/Lung Cancer from 2016 to 2027
-
1.4.5 USA Cytotoxic Drug Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Cytotoxic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Cytotoxic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Cytotoxic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Cytotoxic Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Cytotoxic Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Cytotoxic Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Injection
-
3.4.2 Market Size and Growth Rate of Solid Oral Dose Forms
-
3.4.3 Market Size and Growth Rate of Others
4 Segmentation of Cytotoxic Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Cytotoxic Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Cytotoxic Drug in Breast Cancer
-
4.4.2 Market Size and Growth Rate of Cytotoxic Drug in Blood Cancer
-
4.4.3 Market Size and Growth Rate of Cytotoxic Drug in Prostate Cancer
-
4.4.4 Market Size and Growth Rate of Cytotoxic Drug in Respiratory/Lung Cancer
-
4.4.5 Market Size and Growth Rate of Cytotoxic Drug in Other
5 Market Analysis by Regions
-
5.1 USA Cytotoxic Drug Production Analysis by Regions
-
5.2 USA Cytotoxic Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Cytotoxic Drug Landscape Analysis
-
6.1 West USA Cytotoxic Drug Landscape Analysis by Major Types
-
6.2 West USA Cytotoxic Drug Landscape Analysis by Major End-Users
7 South USA Cytotoxic Drug Landscape Analysis
-
7.1 South USA Cytotoxic Drug Landscape Analysis by Major Types
-
7.2 South USA Cytotoxic Drug Landscape Analysis by Major End-Users
8 Middle West USA Cytotoxic Drug Landscape Analysis
-
8.1 Middle West USA Cytotoxic Drug Landscape Analysis by Major Types
-
8.2 Middle West USA Cytotoxic Drug Landscape Analysis by Major End-Users
9 Northeast USA Cytotoxic Drug Landscape Analysis
-
9.1 Northeast USA Cytotoxic Drug Landscape Analysis by Major Types
-
9.2 Northeast USA Cytotoxic Drug Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Haosoh Pharma
-
10.1.1 Haosoh Pharma Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Eli Lilly
-
10.2.1 Eli Lilly Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Takeda
-
10.3.1 Takeda Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Roche
-
10.4.1 Roche Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Sumitomo Dainippon Pharma
-
10.5.1 Sumitomo Dainippon Pharma Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 eisai
-
10.6.1 eisai Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 AstraZeneca
-
10.7.1 AstraZeneca Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Seattle Genetics
-
10.8.1 Seattle Genetics Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Spectrum Pharma
-
10.9.1 Spectrum Pharma Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Merck
-
10.10.1 Merck Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Sanofi
-
10.11.1 Sanofi Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Celgene
-
10.12.1 Celgene Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Novartis
-
10.13.1 Novartis Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Jazz Pharma
-
10.14.1 Jazz Pharma Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Cytotoxic Drug Market Size and Growth Rate of Injection from 2016 to 2027
-
Figure USA Cytotoxic Drug Market Size and Growth Rate of Solid Oral Dose Forms from 2016 to 2027
-
Figure USA Cytotoxic Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Cytotoxic Drug Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure USA Cytotoxic Drug Market Size and Growth Rate of Blood Cancer from 2016 to 2027
-
Figure USA Cytotoxic Drug Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
Figure USA Cytotoxic Drug Market Size and Growth Rate of Respiratory/Lung Cancer from 2016 to 2027
-
Figure USA Cytotoxic Drug Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Cytotoxic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Cytotoxic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Cytotoxic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Cytotoxic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Cytotoxic Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Cytotoxic Drug
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Cytotoxic Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Cytotoxic Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Injection
-
Figure Market Size and Growth Rate of Solid Oral Dose Forms
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Cytotoxic Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Cytotoxic Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Blood Cancer
-
Figure Market Size and Growth Rate of Prostate Cancer
-
Figure Market Size and Growth Rate of Respiratory/Lung Cancer
-
Figure Market Size and Growth Rate of Other
-
Table USA Cytotoxic Drug Production by Regions
-
Table USA Cytotoxic Drug Production Share by Regions
-
Figure USA Cytotoxic Drug Production Share by Regions in 2016
-
Figure USA Cytotoxic Drug Production Share by Regions in 2021
-
Figure USA Cytotoxic Drug Production Share by Regions in 2027
-
Table USA Cytotoxic Drug Consumption by Regions
-
Table USA Cytotoxic Drug Consumption Share by Regions
-
Figure USA Cytotoxic Drug Consumption Share by Regions in 2016
-
Figure USA Cytotoxic Drug Consumption Share by Regions in 2021
-
Figure USA Cytotoxic Drug Consumption Share by Regions in 2027
-
Table West USA Cytotoxic Drug Consumption by Types from 2016 to 2027
-
Table West USA Cytotoxic Drug Consumption Share by Types from 2016 to 2027
-
Figure West USA Cytotoxic Drug Consumption Share by Types in 2016
-
Figure West USA Cytotoxic Drug Consumption Share by Types in 2021
-
Figure West USA Cytotoxic Drug Consumption Share by Types in 2027
-
Table West USA Cytotoxic Drug Consumption by End-Users from 2016 to 2027
-
Table West USA Cytotoxic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Cytotoxic Drug Consumption Share by End-Users in 2016
-
Figure West USA Cytotoxic Drug Consumption Share by End-Users in 2021
-
Figure West USA Cytotoxic Drug Consumption Share by End-Users in 2027
-
Table South USA Cytotoxic Drug Consumption by Types from 2016 to 2027
-
Table South USA Cytotoxic Drug Consumption Share by Types from 2016 to 2027
-
Figure South USA Cytotoxic Drug Consumption Share by Types in 2016
-
Figure South USA Cytotoxic Drug Consumption Share by Types in 2021
-
Figure South USA Cytotoxic Drug Consumption Share by Types in 2027
-
Table South USA Cytotoxic Drug Consumption by End-Users from 2016 to 2027
-
Table South USA Cytotoxic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Cytotoxic Drug Consumption Share by End-Users in 2016
-
Figure South USA Cytotoxic Drug Consumption Share by End-Users in 2021
-
Figure South USA Cytotoxic Drug Consumption Share by End-Users in 2027
-
Table Middle West USA Cytotoxic Drug Consumption by Types from 2016 to 2027
-
Table Middle West USA Cytotoxic Drug Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Cytotoxic Drug Consumption Share by Types in 2016
-
Figure Middle West USA Cytotoxic Drug Consumption Share by Types in 2021
-
Figure Middle West USA Cytotoxic Drug Consumption Share by Types in 2027
-
Table Middle West USA Cytotoxic Drug Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Cytotoxic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Cytotoxic Drug Consumption Share by End-Users in 2016
-
Figure Middle West USA Cytotoxic Drug Consumption Share by End-Users in 2021
-
Figure Middle West USA Cytotoxic Drug Consumption Share by End-Users in 2027
-
Table Northeast USA Cytotoxic Drug Consumption by Types from 2016 to 2027
-
Table Northeast USA Cytotoxic Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Cytotoxic Drug Consumption Share by Types in 2016
-
Figure Northeast USA Cytotoxic Drug Consumption Share by Types in 2021
-
Figure Northeast USA Cytotoxic Drug Consumption Share by Types in 2027
-
Table Northeast USA Cytotoxic Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Cytotoxic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Cytotoxic Drug Consumption Share by End-Users in 2016
-
Figure Northeast USA Cytotoxic Drug Consumption Share by End-Users in 2021
-
Figure Northeast USA Cytotoxic Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Haosoh Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Haosoh Pharma
-
Figure Sales and Growth Rate Analysis of Haosoh Pharma
-
Figure Revenue and Market Share Analysis of Haosoh Pharma
-
Table Product and Service Introduction of Haosoh Pharma
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Takeda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda
-
Figure Sales and Growth Rate Analysis of Takeda
-
Figure Revenue and Market Share Analysis of Takeda
-
Table Product and Service Introduction of Takeda
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Sumitomo Dainippon Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sumitomo Dainippon Pharma
-
Figure Sales and Growth Rate Analysis of Sumitomo Dainippon Pharma
-
Figure Revenue and Market Share Analysis of Sumitomo Dainippon Pharma
-
Table Product and Service Introduction of Sumitomo Dainippon Pharma
-
Table Company Profile and Development Status of eisai
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of eisai
-
Figure Sales and Growth Rate Analysis of eisai
-
Figure Revenue and Market Share Analysis of eisai
-
Table Product and Service Introduction of eisai
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Seattle Genetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seattle Genetics
-
Figure Sales and Growth Rate Analysis of Seattle Genetics
-
Figure Revenue and Market Share Analysis of Seattle Genetics
-
Table Product and Service Introduction of Seattle Genetics
-
Table Company Profile and Development Status of Spectrum Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharma
-
Figure Sales and Growth Rate Analysis of Spectrum Pharma
-
Figure Revenue and Market Share Analysis of Spectrum Pharma
-
Table Product and Service Introduction of Spectrum Pharma
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Celgene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
-
Figure Sales and Growth Rate Analysis of Celgene
-
Figure Revenue and Market Share Analysis of Celgene
-
Table Product and Service Introduction of Celgene
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Jazz Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jazz Pharma
-
Figure Sales and Growth Rate Analysis of Jazz Pharma
-
Figure Revenue and Market Share Analysis of Jazz Pharma
-
Table Product and Service Introduction of Jazz Pharma
-
